Dendritic cells and myeloid leukaemias: Plasticity and commitment in cell differentiation

British Journal of Haematology

Volumn 138, Issue 3, 2007, Pages 281-290

  Rasaiyaah, Jane ^a   Yong, Kwee ^a   Katz, David R ^a   Kellam, Paul ^a   Chain, Benjamin M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acute myeloid leukaemia; Chronic myeloid leukaemia; Dendritic cell; French American British classification; Leukaemia

Indexed keywords

BRYOSTATIN 1; CALCITRIOL; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; PHORBOL 13 ACETATE 12 MYRISTATE; STEM CELL FACTOR; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; CELL DIFFERENTIATION; CELL MATURATION; CHRONIC MYELOID LEUKEMIA; DENDRITIC CELL; DISEASE CLASSIFICATION; HUMAN; LEUKEMIA CELL; MYELOID LEUKEMIA; MYELOMONOCYTIC LEUKEMIA; PLASTICITY; PRIORITY JOURNAL; REVIEW; STIMULUS RESPONSE;

ACUTE DISEASE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL LINEAGE; CHRONIC DISEASE; DENDRITIC CELLS; HUMANS; IMMUNITY, NATURAL; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA, MYELOID;

EID: 34447128838     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06622.x     Document Type: Review

References (65)

1. Ackerman, A.L. Cresswell, P. (2003) Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1. Journal of Immunology, 170, 4178 4188.
2. Ardavin, C., Martinez del Hoyo, G., Martin, P., Anjuere, F., Arias, C.F., Marin, A.R., Ruiz, S., Parrillas, V. Hernandez, H. (2001) Origin and differentiation of dendritic cells. Trends in Immunology, 22, 691 700.
3. Azam, P., Peiffer, J.L., Chamousset, D., Tissier, M.H., Bonnet, P.A., Vian, L., Fabre, I. Ourlin, J.C. (2005) The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. Toxicology and Applied Pharmacology, 212, 14 23.
4. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B. Palucka, K. (2000) Immunobiology of dendritic cells. Annual Review of Immunology, 18, 767 811.
5. Bastie, J.N., Balitrand, N., Guillemot, I., Chomienne, C. Delva, L. (2005) Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled. Experimental Cell Research, 310, 319 330.
6. Berges, C., Naujokat, C., Tinapp, S., Wieczorek, H., Hoh, A., Sadeghi, M., Opelz, G. Daniel, V. (2005) A cell line model for the differentiation of human dendritic cells. Biochemical and Biophysical Research Communications, 333, 896 907.
7. Bontkes, H.J., Ruizendaal, J.J., Kramer, D., Santegoets, S.J., Scheper, R.J., de Gruijl, T.D., Meijer, C.J. Hooijberg, E. (2006) Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells. Journal of Immunotherapy, 29, 188 200.
8. Brackman, D., Lund-Johansen, F. Aarskog, D. (1995) Expression of cell surface antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3, retinoic acid and DMSO. Leukemia Research, 19, 57 64.
9. Bradstock, K.F. (2002) The use of hematopoietic growth factors in the treatment of acute leukemia. Current Pharmaceutical Design, 8, 343 355.
10. Brouwer, R.E., der Hoorn, M., Kluin-Nelemans, H.C., van Zelderen-Bhola, S., Willemze, R. Falkenburg, J.H. (2000) The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses. Human Immunology, 61, 565 574.
11. Buggins, A.G., Milojkovic, D., Arno, M.J., Lea, N.C., Mufti, G.J., Thomas, N.S. Hirst, W.J. (2001) Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. Journal of Immunology, 167, 6021 6030.
12. Choi, B.H., Kang, H.K., Park, J.S., Kim, S.K., Pham, T.N., Zhu, X.W., Cho, D., Nam, J.H., Chung, I.J., Kim, Y.J., Rhee, J.H., Kim, H.J. Lee, J.J. (2006) Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy. Journal of Clinical Apheresis, 21, 233 240.
13. Choudhury, A., Gajewski, J.L., Liang, J.C., Popat, U., Claxton, D.F., Kliche, K.O., Andreeff, M. Champlin, R.E. (1997) Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood, 89, 1133 1142.
14. Cignetti, A., Bryant, E., Allione, B., Vitale, A., Foa, R. Cheever, M.A. (1999) CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood, 94, 2048 2055.
15. Clark, C.S., Konyer, J.E. Meckling, K.A. (2004) 1alpha,25- dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression. Experimental Cell Research, 294, 301 311.
16. Collins, S.J. (1987) The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood, 70, 1233 1244.
17. Curti, A., Pandolfi, S., Aluigi, M., Isidori, A., Alessandrini, I., Chiodoni, C., Testoni, N., Colombo, M.P., Baccarani, M. Lemoli, R.M. (2005) Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells. Experimental Hematology, 33, 1521 1530.
18. Dalton, W.T. Jr., Ahearn, M.J., McCredie, K.B., Freireich, E.J., Stass, S.A. Trujillo, J.M. (1988) HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood, 71, 242 247.
19. Dodd, R.C., Cohen, M.S., Newman, S.L. Gray, T.K. (1983) Vitamin D metabolites change the phenotype of monoblastic U937 cells. Proceedings of the National Academy of Sciences of the United States of America, 80, 7538 7541.
20. Drexler, H.G., Quentmeier, H., MacLeod, R.A., Uphoff, C.C. Hu, Z.B. (1995) Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia. Leukemia Research, 19, 681 691.
21. Eaves, C., Cashman, J. Eaves, A. (1998) Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia. Leukemia Research, 22, 1085 1096.
22. Fauriat, C., Moretta, A., Olive, D. Costello, R.T. (2005) Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients. Blood, 106, 2186 2188.
23. Fazekas De St Groth, B., L Smith, A., Bosco, J., Sze, D.M., Power, C.A. Austen, F.I. (2002) Experimental models linking dendritic cell lineage, phenotype and function. Immunology and Cell Biology, 80, 469 476.
24. Hagihara, M., Shimakura, Y., Tsuchiya, T., Ueda, Y., Gansuvd, B., Munkhbat, B., Chargui, J., Ando, K., Kato, S. Hotta, T. (2001) The efficient generation of CD83 positive immunocompetent dendritic cells from CD14 positive acute myelomonocytic or monocytic leukemia cells in vitro. Leukemia Research, 25, 249 258.
25. Harris, P. Ralph, P. (1985) Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. Journal of Leukocyte Biology, 37, 407 422.
26. Harrison, B.D., Adams, J.A., Briggs, M., Brereton, M.L. Yin, J.A. (2001) Stimulation of autologous proliferative and cytotoxic T-cell responses by ''leukemic dendritic cells'' derived from blast cells in acute myeloid leukemia. Blood, 97, 2764 2771.
27. Hart, D.N. (1997) Dendritic cells: unique leukocyte populations which control the primary immune response. Blood, 90, 3245 3287.
28. Hass, R. (1992) Retrodifferentiation - an alternative biological pathway in human leukemia cells. European Journal of Cell Biology, 58, 1 11.
29. Houtenbos, I., Westers, T.M., Ossenkoppele, G.J. van de Loosdrecht, A.A. (2003) Identification of CD14 as a predictor for leukemic dendritic cell differentiation in acute myeloid leukemia. Leukemia 17, 1685 van de Loosdrecht, A.A. (2006a) Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia. Haematologica, 91, 348 355.
30. Houtenbos, I., Westers, T.M., Hess, C.J., Waisfisz, Q., Ossenkoppele, G.J. de Loosdrecht, A.A. (2006b) Flt-3 internal tandem duplication hampers differentiation of AML blasts towards leukemic dendritic cells. Leukemia, 20, 1892 1895.
31. Hulette, B.C., Rowden, G., Ryan, C.A., Lawson, C.M., Dawes, S.M., Ridder, G.M. Gerberick, G.F. (2001) Cytokine induction of a human acute myelogenous leukemia cell line (KG-1) to a CD1a+ dendritic cell phenotype. Archives of Dermatological Research, 293, 147 158.
32. Ibrahim, M.A., Chain, B.M. Katz, D.R. (1995) The injured cell: the role of the dendritic cell system as a sentinel receptor pathway. Immunology Today, 16, 181 186.
33. James, S.Y., Williams, M.A., Newland, A.C. Colston, K.W. (1999) Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. General Pharmacology, 32, 143 154.
34. Kang, H.K., Park, J.S., Kim, S.K., Choi, B.H., Pham, T.N., Zhu, X.W., Cho, D., Nam, J.H., Kim, Y.J., Rhee, J.H., Chung, I.J., Kim, H.J. Lee, J.J. (2006) Down-regulation of cellular vascular endothelial growth factor levels induces differentiation of leukemic cells to functional leukemic-dendritic cells in acute myeloid leukemia. Leukemia and Lymphoma, 47, 2224 2233.
35. Kim, K.D., Choi, S.C., Noh, Y.W., Kim, J.W., Paik, S.G., Yang, Y., Kim K., II. Lim, J.S. (2006) Impaired responses of leukemic dendritic cells derived from a human myeloid cell line to LPS stimulation. Experimental and Molecular Medicine, 38, 72 84.
36. de Klein, A., van Agthoven, T., Groffen, C., Heisterkamp, N., Groffen, J. Grosveld, G. (1986) Molecular analysis of both translocation products of a Philadelphia-positive CML patient. Nucleic Acids Research, 14, 7071 7082.
37. Koski, G.K., Schwartz, G.N., Weng, D.E., Gress, R.E., Engels, F.H., Tsokos, M., Czerniecki, B.J. Cohen, P.A. (1999) Calcium ionophore-treated myeloid cells acquire many dendritic cell characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents. Blood, 94, 1359 1371.
38. Kufner, S., Fleischer, R.P., Kroell, T., Schmid, C., Zitzelsberger, H., Salih, H., de Valle, F., Treder, W. Schmetzer, H.M. (2005a) Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes. Cancer Immunology, Immunotherapy, 54, 953 970.
39. Kufner, S., Zitzelsberger, H., Kroell, T., Pelka-Fleischer, R., Salem, A., de Valle, F., Schweiger, C., Nuessler, V., Schmid, C., Kolb, H.J. Schmetzer, H.M. (2005b) Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions. Scandinavian Journal of Immunology, 62, 86 98.
40. Larsson, K., Lindstedt, M. Borrebaeck, C.A. (2006) Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology, 117, 156 166.
41. Lindner, I., Kharfan-Dabaja, M.A., Ayala, E., Kolonias, D., Carlson, L.M., Beazer-Barclay, Y., Scherf, U., Hnatyszyn, J.H. Lee, K.P. (2003) Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL. Journal of Immunology, 171, 1780 1791.
42. Masterson, A.J., Sombroek, C.C., De Gruijl, T.D., Graus, Y.M., van der Vliet, H.J., Lougheed, S.M., van den Eertwegh, A.J., Pinedo, H.M. Scheper, R.J. (2002) MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood, 100, 701 703.
43. Michor, F., Hughes, T.P., Iwasa, Y., Branford, S., Shah, N.P., Sawyers, C.L. Nowak, M.A. (2005) Dynamics of chronic myeloid leukaemia. Nature, 435, 1267 1270.
44. Mohty, M., Isnardon, D., Blaise, D., Mozziconacci, M.J., Lafage-Pochitaloff, M., Briere, F., Gastaut, J.A., Olive, D. Gaugler, B. (2002) Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia. Leukemia, 16, 2267 2274.
45. Montanari, M., Gemelli, C., Tenedini, E., Zanocco Marani, T., Vignudelli, T., Siena, M., Zini, R., Salati, S., Chiossi, G., Tagliafico, E., Manfredini, R., Grande, A. Ferrari, S. (2005) Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors. Cell Death and Differentiation, 12, 1588 1600.
46. Nakajima, H., Kizaki, M., Ueno, H., Muto, A., Takayama, N., Matsushita, H., Sonoda, A. Ikeda, Y. (1996) All-trans and 9-cis retinoic acid enhance 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells. Leukemia Research, 20, 665 676.
47. Narita, M., Takahashi, M., Liu, A., Nikkuni, K., Furukawa, T., Toba, K., Koyama, S., Takai, K., Sanada, M. Aizawa, Y. (2001) Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia. Experimental Hematology, 29, 709 719.
48. Neame, P.B., Soamboonsrup, P., Browman, G.P., Meyer, R.M., Benger, A., Wilson, W.E., Walker, I.R., Saeed, N. McBride, J.A. (1986) Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML. Blood, 68, 1355 1362.
49. Orsini, E., Calabrese, E., Maggio, R., Pasquale, A., Nanni, M., Trasarti, S., Tafuri, A., Guarini, A. Foa, R. (2006) Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation. Leukemia Research, 30, 785 794.
50. Park, H.Y., Park, J.Y., Kim, J.W., Lee, M.J., Jang, M.J., Lee, S.Y., Baek, D.W., Park, Y.M., Lee, S.W., Yoon, S., Bae, Y.S. Kwak, J.Y. (2004) Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line. International Immunopharmacology, 4, 1587 1601.
51. Puig-Kroger, A., Serrano-Gomez, D., Caparros, E., Dominguez-Soto, A., Relloso, M., Colmenares, M., Martinez-Munoz, L., Longo, N., Sanchez-Sanchez, N., Rincon, M., Rivas, L., Sanchez-Mateos, P., Fernandez-Ruiz, E. Corbi, A.L. (2004) Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin in THP-1 human leukemic cells, monocytes, and macrophages. Journal of Biological Chemistry, 279, 25680 25688.
52. Reid, C.D., Stackpoole, A., Meager, A. Tikerpae, J. (1992) Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. Journal of Immunology, 149, 2681 2688.
53. Sallusto, F. Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. Journal of Experimental Medicine, 179, 1109 1118.
54. Santegoets, S.J., Schreurs, M.W., Masterson, A.J., Liu, Y.P., Goletz, S., Baumeister, H., Kueter, E.W., Lougheed, S.M., van den Eertwegh, A.J., Scheper, R.J., Hooijberg, E. de Gruijl, T.D. (2006) In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line. Cancer Immunology, Immunotherapy, 00, 1 11.
55. Santiago-Schwarz, F., Coppock, D.L., Hindenburg, A.A. Kern, J. (1994) Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood, 84, 3054 3062.
56. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D. Dirks, P.B. (2004) Identification of human brain tumour initiating cells. Nature, 432, 396 401.
57. Song, J.H., Kim, J.M., Kim, S.H., Kim, H.J., Lee, J.J., Sung, M.H., Hwang, S.Y. Kim, T.S. (2003) Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sciences, 73, 1705 1719.
58. St Louis, D.C., Woodcock, J.B., Franzoso, G., Blair, P.J., Carlson, L.M., Murillo, M., Wells, M.R., Williams, A.J., Smoot, D.S., Kaushal, S., Grimes, J.L., Harlan, D.M., Chute, J.P., June, C.H., Siebenlist, U. Lee, K.P. (1999) Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model. Journal of Immunology, 162, 3237 3248.
59. Stonehouse, T.J., Woodhead, V.E., Herridge, P.S., Ashrafian, H., George, M., Chain, B.M. Katz, D.R. (1999) Molecular characterization of U937-dependent T-cell co-stimulation. Immunology, 96, 35 47.
60. Suciu-Foca Cortesini, N., Piazza, F., Ho, E., Ciubotariu, R., LeMaoult, J., Dalla-Favera, R. Cortesini, R. (2001) Distinct mRNA microarray profiles of tolerogenic dendritic cells. Human Immunology, 62, 1065 1072.
61. Terme, M., Borg, C., Guilhot, F., Masurier, C., Flament, C., Wagner, E.F., Caillat-Zucman, S., Bernheim, A., Turhan, A.G., Caignard, A. Zitvogel, L. (2005) BCR/ABL promotes dendritic cell-mediated natural killer cell activation. Cancer Research, 65, 6409 6417.
62. Tosi, G., Jabrane-Ferrat, N. Peterlin, B.M. (2002) Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters. EMBO Journal, 21, 5467 5476.
63. Trayner, I.D., Bustorff, T., Etches, A.E., Mufti, G.J., Foss, Y. Farzaneh, F. (1998) Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, alpha1,25- dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate. Leukemia Research, 22, 537 547.
64. White, S.L., Belov, L., Barber, N., Hodgkin, P.D. Christopherson, R.I. (2005) Immunophenotypic changes induced on human HL60 leukaemia cells by 1alpha,25-dihydroxyvitamin D3 and 12-O-tetradecanoyl phorbol-13-acetate. Leukemia Research, 29, 1141 1151.
65. Woiciechowsky, A., Regn, S., Kolb, H.J. Roskrow, M. (2001) Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia. Leukemia, 15, 246 255.